Our care team participates in the Huntsman
Tumor Boards for challenging cases with experts from a range of specialties.
The clinical consequences of the molecular results are discussed in Molecular
Tumor Boards for novel treatment strategies.
Not exact matches
If you ask Bill Doyle, the executive chairman of the
board of Novocure, the two - pronged strategy
for expanding his
tumor - tackling biotechnology company is «relatively simple.»
The Moores Cancer Center's Molecular
Tumor Board brought together medical, surgical and radiation therapy oncologists, biostatisticians, radiologists, pathologists, clinical geneticists, basic and translational science researchers, and bioinformatics and pathway analysis specialists to discuss the intricacies of tumor genetics and tailor a personalized treatment plan for patients with advanced cancer or who have exhausted standard thera
Tumor Board brought together medical, surgical and radiation therapy oncologists, biostatisticians, radiologists, pathologists, clinical geneticists, basic and translational science researchers, and bioinformatics and pathway analysis specialists to discuss the intricacies of
tumor genetics and tailor a personalized treatment plan for patients with advanced cancer or who have exhausted standard thera
tumor genetics and tailor a personalized treatment plan
for patients with advanced cancer or who have exhausted standard therapies.
Coupled with a review of these results by experts on a molecular
tumor board, the opportunity exists to identify novel therapies that would target specific abnormalities,» notes senior author of the work, Shridar Ganesan, MD, PhD, associate director
for translational science at Rutgers Cancer Institute and associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.
Genomic alterations were reviewed by the Institute's molecular
tumor board and recommendations
for patient treatment options were made regarding genomically targeted therapies either already approved or used investigationally — including clinical trials.
Pediatric oncologists, surgeons, radiation oncologists, pathologists, radiologists and nuclear medicine physicians attend the
Tumor Board, allowing
for our collective expertise to provide a thorough, comprehensive approach to the care of children with cancer.
Our specialists prepare a comprehensive treatment plan
for each patient, developed jointly through
tumor board meetings featuring representatives of each specialty involved in your care.
Pediatric oncologists, surgeons, radiation oncologists, pathologists, radiologists and nuclear medicine physicians attend the
Tumor Board, allowing
for our collective expertise to provide thorough, comprehensive approach to the care of children with cancer.
Once these analyses are completed, a «
tumor board» of researchers and oncologists will help decide which therapies might work best
for each individual patient.
«PALLADIA is an exciting, new treatment option
for dogs with mast cell
tumors,» said Cheryl London, DVM, PhD,
board certified medical oncologist and associate professor at The Ohio State University College of Veterinary Medicine.
As the only veterinarians in Miami that are
board - certified by the American College of Veterinary Internal Medicine Specialty of Neurology, we aim to be an extension of your hospital
for complicated neurological cases including paralysis, difficulty walking, pain that does not respond to medications, seizure management, balance disorders, spinal fractures, head trauma, brain
tumors, spinal
tumors, strokes, encephalitis and atlantoaxial instability.
Seeking detail oriented candidate
for Registry Clerk position ordering supplies, planning and carrying out the complete process of weekly
Tumor Boards, answering phones, & performing follow - up.